Nasdaq: UTHR
United Therapeutics insiders
The officers, directors and 10% owners of United Therapeutics Corporation who hold the most stock, valued at the live UTHR price.
$559.10
UTHR today −$18.2M (−3.16%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 8
- Their UTHR stock
- $461M
- Market value
- $23.81B
- Held by ranked insiders
- 1.93%
Insiders by value of UTHR holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Martine A. Rothblatt | Chairperson & CEO | 668,728 | $374M | 1.57% | 572nd |
| 2 | Paul A. Mahon | EVP & GENERAL COUNSEL | 45,172 | $25.3M | 0.11% | 4340th |
| 3 | Michael Benkowitz | PRESIDENT AND COO | 27,893 | $15.6M | <0.1% | 6235th |
| 4 | Tommy G. Thompson | Director | 22,480 | $12.6M | <0.1% | 3591st |
| 5 | Richard Giltner | Director | 21,884 | $12.2M | <0.1% | 7555th |
| 6 | James Edgemond | CFO AND TREASURER | 18,876 | $10.6M | <0.1% | 8437th |
| 7 | Ray Kurzweil | Director | 13,320 | $7.4M | <0.1% | 10888th |
| 8 | Judy D. Olian | Director | 5,555 | $3.1M | <0.1% | 10481st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for United Therapeutics; see each profile for the filing.